Multi-Omic SignAtures of Inflammatory Cutaneous Diseases
NCT07771673 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-08-18
Summary
The goal of this observational study is to identify the immune profile underlying various inflammatory skin diseases, through multi-omic procedures.
The main questions it aims to answer are:
1. What are the molecular and immune signatures of individuals with inflammatory skin disease?
2. Can these signatures reveal potential therapeutic targets for individuals with inflammatory skin disease?
3. How do patients' multi-omic signatures change before and after receiving systemic therapy?
4. Can the samples and data collected through this study provide a valuable bioresource for future skin disease research?
Conditions
- Inflammatory Skin Conditions
Sponsors & Collaborators
-
LifeArc
collaborator OTHER -
DEBRA
collaborator UNKNOWN -
Guy's and St Thomas' NHS Foundation Trust
lead OTHER
Principal Investigators
-
Su M Lwin, MRCP (Derm) PhD BSc (Hons) · King's College London
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-30
- Primary Completion
- 2031-07-31
- Completion
- 2031-07-31
More Related Trials
-
IL-17 Role in Variants of Psoriasis
NCT02078297 ·Status: COMPLETED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: ENROLLING_BY_INVITATION
-
A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
NCT03073213 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
NCT06082323 ·Status: COMPLETED ·Phase: PHASE1
-
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
NCT03361215 ·Status: RECRUITING
-
Evolution of Chronic Inflammatory Skin Diseases
NCT07708896 ·Status: NOT_YET_RECRUITING
-
Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring
NCT04809571 ·Status: UNKNOWN ·Phase: NA
-
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
NCT06136403 ·Status: RECRUITING ·Phase: PHASE2
-
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
NCT06167408 ·Status: COMPLETED
-
TL1A Expression in Psoriatic Skin
NCT01744327 ·Status: UNKNOWN
-
Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis
NCT06610942 ·Status: NOT_YET_RECRUITING
-
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
NCT06742333 ·Status: RECRUITING ·Phase: PHASE2
-
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NCT05503875 ·Status: RECRUITING ·Phase: NA
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN
-
TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
NCT01657513 ·Status: UNKNOWN ·Phase: NA
-
A Study of Deucravacitinib to Treat LPP and FFA
NCT06091956 ·Status: COMPLETED ·Phase: PHASE2
-
Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis
NCT07386717 ·Status: COMPLETED
-
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
NCT01782937 ·Status: COMPLETED ·Phase: PHASE3
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Effect of Chronic Inflammation on Myocardial Perfusion and Function
NCT04870827 ·Status: TERMINATED
-
Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.
NCT07492251 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis
NCT06374979 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
NCT05316805 ·Status: RECRUITING
-
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
NCT03629379 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis
NCT04459780 ·Status: COMPLETED ·Phase: NA